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Dientamoeba fragilis is a protozoan parasite of humans that infects the mucosa of the large intestine and is
associated with gastrointestinal disease. We developed a 5 nuclease (TaqMan)-based real-time PCR assay,
targeting the small subunit rRNA gene, for the detection of D. fragilis in human stool specimens and compared
its sensitivity and specificity to conventional PCR and microscopic examination by a traditional modified
iron-hematoxylin staining procedure. Real-time PCR exhibited 100% sensitivity and specificity.
Dientamoeba fragilis is a pathogenic protozoan parasite, of-
ten more prevalent than Giardia intestinalis, which causes gas-
trointestinal disease in humans (5, 7, 9, 17). Due to the pro-
pensity of this organism to cause chronic infection, it is
essential that correct diagnosis occur promptly (3, 4, 7, 9, 13,
17). Two genotypes of D. fragilis have been described by anal-
ysis of the small subunit rRNA gene (10, 12, 17, 22), with only
one predominant in Australia (17).
Diagnosis of D. fragilis relies on direct visualization of the
trophozoites in stained fixed fecal smears by light microscopy,
as demonstration of the characteristic nuclear structure cannot
be achieved in unstained fecal specimens (4). D. fragilis may be
difficult to distinguish from nonpathogenic protozoa (9).
The aim of this study was to develop a real-time PCR method
that is rapid, highly sensitive, and specific for the detection of D.
fragilis in fecal specimens. Results from the real-time assay were
compared to those derived by a conventional PCR and micro-
scopic examination using a traditional modified iron-hematoxylin
staining procedure in order to determine the usefulness and prac-
ticality of this real-time PCR test.
(This research was performed by Damien Stark in partial ful-
fillment for the degree of Ph.D. at University of Technology
Sydney.)
Entamoeba histolytica HM-1:IMSS (ATCC strain 30459) and
Trichomonas vaginalis (ATCC strain F1623) were passaged in
TYI-S-33 broth: genomic DNA was extracted from them using
a QIAamp DNA minikit (QIAGEN, Hilden, Germany).
Stool specimens used in this study were those submitted to
St. Vincent’s Hospital Department of Microbiology, Sydney,
for investigation of diarrhea. Portions of all stool samples were
fixed in sodium acetate-acetic acid-formalin and permanently
stained using a modified iron-hematoxylin stain (Fronine,
Australia) according to the manufacturer’s recommendations.
DNA was extracted from fresh fecal specimens (24 h old)
using a QIAamp DNA stool minikit (QIAGEN, Hilden, Germany)
according to the manufacturer’s protocol. To ensure we were
using “best practice” for the preparation of DNA from stool
specimens using this kit, we also evaluated a modification of
the manufacturer’s instructions (8) using four samples positive
for D. fragilis by microscopy. As a control, these same samples
were also extracted following the manufacturer’s instructions,
and the two sets of DNA were then tested with conventional
and real-time PCR.
The small subunit (SSU) rRNA genes from D. fragilis was
amplified using the primers TRD3-TRD5 (16), and the 1.8-kb
product was cloned into the PCR cloning TA vector, as de-
scribed by the manufacturer (Invitrogen). After transformation
into Escherichia coli (strain DH5), individual transformants
were screened for the presence of cloned DNA by PCR. Plas-
mid DNA from one of these clones (pDf18S rRNA genes) was
purified from bacterial cultures grown in L broth using stan-
dard procedures. The purified recombinant DNA was quanti-
fied, determined to contain only one insert, and used for the
sensitivity testing of the conventional and real-time PCR. Con-
ventional PCR and DNA sequencing, using primers DF 400-
DF1250 and DF3-DF4, were performed according to Stark
et al. (16). Inhibition controls, comprising patient fecal sam-
ples spiked with cloned D. fragilis SSU rRNA genes, were also
run to rule out PCR inhibition.
The SSU rRNA gene sequences present in GenBank from
enteric protozoa normally associated with clinical signs of gastro-
intestinal disease in humans were aligned using the computer
program Pileup. From this multiple sequence alignment, the fol-
lowing D. fragilis-specific primers and probe were developed: DF3
(5-GTTGAATACGTCCCTGCCCTTT-3), DF4 (5-TGATCC
AATGATTTCACCGAGTCA-3), and dual-labeled TaqMan
probe (5-6-carboxyfluorescein-CACACCGCCCGTCGCTCC
TACCG-6-carboxytetramethylrhodamine-3).
Real-time PCR was performed using a LightCycler (Roche)
in a 20-l reaction volume in a glass capillary tube containing
2 l of FastStart reaction mix hybridization probes (a compo-
nent of the FastStart DNA master hybridization probes kit;
Roche Diagnostics), 3 mM MgCl2, 0.25 M forward and re-
verse primer, 0.2 M dual-labeled fluorescent probe, and 2 l
of DNA extract.
Reaction conditions were as follows: 10 min at 95°C fol-
lowed by 35 cycles of 95°C, 10 s at 58°C, and 3 s at 72°C.
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Temperature change rates were at 20°C/s. Readout was per-
formed in channel F1.
To determine the sensitivity and detection limit of the PCR
assay, known concentrations of pDf18S rRNA genes were se-
rially diluted down to approximately 1 plasmid copy. These
controls were then run with both the conventional PCR and
the real-time PCR.
Optimal extraction of DNA from human feces was achieved
by using a commercial kit with no modifications to the extrac-
tion procedure. Both the modified and unmodified method
produced amplicons in both conventional and real-time PCR.
Given that the modified extraction procedure greatly increased
the time taken to process the specimens (1 h), it was deemed
that the extra steps taken were not needed. This is in contrast
to a study that used the modified technique for extraction of
DNA from feline feces (8).
A total of 200 fecal samples were screened by microscopy and
conventional and real-time PCR. All 200 fecal samples spiked
FIG. 2. Evaluation of sensitivity of real-time PCR using cloned DNA. The results show that the following amounts of target are detectable:
sample 1, 10,000,000 rRNA gene copies; sample 2, 1,000,000 rRNA gene copies; sample 3, 100,000 rRNA gene copies; sample 4, 10,000 rRNA gene
copies; sample 5, 1,000 rRNA gene copies; sample 6, 100 rRNA gene copies; sample 7, 10 rRNA gene copies; sample 8, 1 rRNA gene copy. Sample
10 is a negative control.
FIG. 1. Detection of D. fragilis in feces by real-time PCR. One sample is a positive control, one sample is a negative control, and 30 samples
are D. fragilis microscopy-positive samples.
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with pDf18S rRNA genes amplified the correct PCR product,
showing that PCR inhibition was not an issue in this study.
Real-time PCR of the samples detected a total of 51 positives
(Fig. 1), conventional PCR detected 48 and microscopy 50 D.
fragilis-positive while samples. One sample positive by microscopy
and negative by both PCR methods was subsequently deemed a
false positive when the permanently stained smear was reexam-
ined by an independent experienced microscopist who concluded
that the nonpathogenic Endolimax nana was misidentified as D.
fragilis. Two samples of the 150 deemed negative for D. fragilis by
permanent staining produced amplicons by real-time PCR. One
of these samples gave a product with conventional PCR. Upon
sequencing of these amplicons, they were confirmed to be derived
from D. fragilis DNA by DNA sequence comparisons. One of the
150 samples negative by microscopy was positive by conventional
PCR, while 2 of the 150 microscopy samples were positive by
real-time PCR. One of these samples contained Blastocystis homi-
nis and E. nana, while the other contained the Entamoeba histo-
lytica/dispar complex, and on subsequent review of each perma-
nent slide, no D. fragilis was detected by microscopy.
To determine the specificity of the real-time PCR, 29 spec-
imens containing various other protozoan parasites (Table 1)
underwent direct DNA extraction from fresh stool samples. No
PCR products were obtained from any of these specimens. A
further 29 specimens containing no protozoa underwent direct
DNA extraction on fresh stool samples. No PCR products
were detected in this group either. To further determine any
cross-reactivity of the real-time assay, PCR was also performed
on genomic DNA from strains of E. histolytica, T. vaginalis, and
Trichomonas fetus (ATCC strain 3000). Only T. vaginalis and T.
fetus DNA produced a PCR product by this technique.
To determine the sensitivity of both conventional and real-
time PCR, a known number of copies of pDf18S rRNA genes
were then amplified using the same conditions as for the pa-
tients’ samples. This showed that the detection limit was 100
plasmid copies or an equivalent of approximately 1.0 D. fragilis
trophozoite for conventional PCR. The detection limit for the
real-time PCR was determined at 1 plasmid copy (a crossing
point of 27.87) of the SSU rRNA gene, which is equivalent to
approximately 0.01 D. fragilis trophozoite (Fig. 1). It should be
noted that we are describing analytical sensitivity and not clin-
ical sensitivity, and these results may differ from those obtained
using clinical stool specimens. DNA from stool is complex,
containing human, fungal, and plant DNA plus organic mate-
rial, as well as DNA from thousands of microorganisms. Thus,
there is considerably more interaction of primers and probes
with this complex fecal DNA than with the purified plasmid.
In summary, based on the analysis of the fecal samples,
microscopy showed 92.4% sensitivity and 98.7% specificity and
conventional PCR showed 88.9% sensitivity and 100% speci-
ficity compared with 100% sensitivity and specificity for real-
time PCR (Table 2).
In this study, we developed a new 5 nuclease (TaqMan)-
based real-time PCR assay, targeting the small subunit rRNA
gene, for the detection of D. fragilis in human stool specimens.
We then evaluated the ability of real-time PCR to detect D.
fragilis in fecal specimens and compared it with conventional
PCR and microscopy.
In the comparison, microscopy missed two positive samples
and also gave a false positive. The preparation of each slide
and the staining procedure using a modified iron-hematoxylin
stain are time-consuming, and considerable expertise is also
required in the reading and interpretation of the slides by the
microscopist. Microscopy showed a sensitivity of 92.4%; this
high sensitivity can be attributed to the amount of time spent
screening and the highly experienced microscopists who were
reading the slides. The conventional PCR detected only 48
positive samples in comparison to the 51 samples detected by
TABLE 1. List of specimens used in this study containing various
other protozoan parasites
Specimen
no. Protozoan parasite(s) present
1 Blastocystis hominis
2 Entamoeba histolytica
3 Entamoeba dispar
4 Entamoeba coli
5 Entamoeba hartmanni
6 Giardia intestinalis
7 Endolimax nana
8 Iodamoeba butschlii
9 Cryptosporidium species
10 Cyclospora species
11 Chilomastix mesnili
12 E. histolytica/dispar complex, E. coli, E. nana, B. hominis,
and Enteromonas hominis
13 E. histolytica/dispar complex, E. coli, E. nana,
and I. butschlii
14 E. hartmanni, E. nana, E. hominis, and B. hominis
15 E. nana, I. butschlii, and B. hominis
16 Cryptosporidium species and B. hominis
17 E. nana, I. butschlii, C. mesnili, and B. hominis
18 G. intestinalis, E. nana, and B. hominis
19 E. coli, E. nana, and B. hominis
20 G. intestinalis, E. coli, E. hartmanni, and E. hominis
21 E. coli, E. nana, I. butschlii, and B. hominis
22 E. histolytica/dispar complex, E. hartmanni, E. hominis,
and B. hominis
23 E. histolytica/dispar complex, E. nana, E. hominis,
and B. hominis
24 E. coli, E. hartmanni, E. nana, I. butschlii, and B. hominis
25 E. hartmanni and E. nana
26 G. intestinalis, E. histolytica/dispar complex, E. hartmanni,
E. coli, E. hominis, I. butschlii, and B. hominis
27 E. histolytica/dispar complex, E. nana, B. hominis, and
Cryptosporidium species
28 C. mesnili, E. hominis, and E. nana
29 G. intestinalis, E. nana, and B. hominis
TABLE 2. Comparison of PCR, conventional PCR, and microscopy
for detection of D. fragilis
Method
No. of
samples
examined
No. of
positive
samples
detected
Sensitivity
(%)a
Specificity
(%)b
Real-time PCR 200 51 100 100
Conventional PCR 200 48 88.9 100
Microscopyc 200 50 92.4 98.7
a Calculated as follows: (number of true positives/[number of true positives 
number of false negatives])  100.
b Calculated as follows: (number of true negatives/[number of true negatives
number of false positives])  100.
c Microscopy was performed using a modified iron-hematoxylin stain (Fronine,
Australia).
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the real-time PCR. This sensitivity of 88.9% for the conven-
tional PCR is lower than has been previously reported (16, 17).
The real-time PCR was shown to possess a higher level of
sensitivity (100%) for the detection of D. fragilis in feces. Real-
time PCR methods have been utilized in several areas of clin-
ical parasitology, including the detection of fecal parasites.
These real-time PCR assays have been shown to be more
sensitive and specific than conventional methods (2, 18, 20, 21).
This study represents the first report of the application of a
real-time PCR assay for the detection of D. fragilis in human
fecal specimens.
Fresh stool samples only were used in this study (24 h old),
as D. fragilis does not produce cysts, and the trophozoites
degenerate rapidly once passed (9). Stark et al. (16) demon-
strated that aged specimens affected the sensitivity of a con-
ventional PCR assay for detecting D. fragilis in stool specimens.
Of the cultured organisms that were studied by PCR, T.
vaginalis and T. fetus DNA produced an amplicon with the
D. fragilis primers, and subsequent alignments of T. vaginalis,
T. fetus, and D. fragilis SSU rRNA genes showed the priming
sites to be highly conserved and almost identical among the
three species. This shows the close relationship D. fragilis has
with other trichomonads (6, 15). However, T. vaginalis and T.
fetus are not found in human stool samples, and the clinical
samples containing other enteric protozoa, including
trichomonads, used in this study (Chilomastix mesnili, Pen-
tatrichomonas hominis, and Enteromonas hominis) did not pro-
duce an amplicon with the primers. This cross-reactivity does
not affect the usefulness of this real-time assay in a clinical
setting. Inhibition controls were carried out to exclude the
possibility of inhibitory substances, and all were negative.
Thus, the real-time PCR was shown to have 100% specificity
for enteric specimens. On a similar note, we have yet to eval-
uate the use of this PCR for T. vaginalis in clinical specimens.
Real-time PCR offers several advantages over conventional
PCR for a diagnostic laboratory, such as increased sensitivity
(1, 11, 14, 19), rapid cycling times, and reduced risk of con-
tamination. The disadvantages of real-time PCR include the cost
of the assay, which is substantially higher than that of either
microscopy or conventional PCR, and the need for specialized
real-time PCR analyzers, which are currently beyond the means
of many laboratories.
In summary, this work is the first report of a real-time PCR
assay specific for D. fragilis. On fresh stools that had undergone
direct DNA extraction promptly (within 24 h), the sensitivity of
the PCR was 100% and the specificity was 100%. The PCR
method is quick (2 h) and simple and so offers a diagnostic
tool other than light microscopy and conventional PCR for the
diagnosis of dientamoebiasis.
This research was funded by St. Vincent’s Hospital.
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